Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the mfn-opts domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/brownpelican/wp-includes/functions.php on line 6114
Exclusive: Shocking Data Suggests Abortion Pill Complications 22 Times Higher Than Previously Reported: ‘FDA Must Reinstate Stronger Safeguards’, by Katherine Hamilton – Brown Pelican Society of Lousiana

Exclusive: Shocking Data Suggests Abortion Pill Complications 22 Times Higher Than Previously Reported: ‘FDA Must Reinstate Stronger Safeguards’, by Katherine Hamilton

The Brew: Lawless Judges Going to Jail as Trump Team Fights Lawfare Crippling the Executive Branch, by John Zmirak

Daily Scripture Readings and Meditations: Unless One Is Born Anew

By looking through insurance data and classifying cases of medication abortions through various medical coding, researchers identified a total of 865,727 mifepristone abortions for a total of 692,873 women, including 566,446 women who had one such abortion and 126,427 women who had multiple abortions... From those incidents, researchers found a total of 94,605 adverse events related to medication abortions. The number includes (see chart). SOURCE: Breitbart

By Katherine Hamilton, Breitbart , April 202565

Katherine Hamilton is a political reporter for Breitbart News. You can follow her on X @thekat_hamilton

While the abortion pill is touted as “safe and effective,” shocking new data suggests complications are 22 times higher than previously reported.

A study from the Ethics and Public Policy Center released on Monday found that 10.93 percent of women who had mifepristone abortions — the first drug used in a two-drug medication abortion regimen — experienced severe complications including sepsis, infection, hemorrhaging, or another serious adverse event within 45 days following the abortion. This percentage is significantly higher than the less than 0.5 percent in clinical trials reported on the FDA-approved drug label.

The study is the “largest-known study of the abortion pill,” according to the authors, Ethics and Public Policy Center President Ryan T. Anderson and Director of Data Analysis and Fellow Jamie Bryan Hall. The study is based on analysis of data from an all-payer insurance claims database that includes 865,727 prescribed mifepristone abortions from 2017 to 2023 — meaning the results of the study are based on real-world incidents. The data was studied by a team of data scientists, analysts, and engineers, and a clinical team of board-certified obstetricians and gynecologists assisted, they wrote. …

Continue reading >>>>>>>>